Systemic treatment of severe psoriasis--the role of cyclosporine. 1991

N J Lowe

UI MeSH Term Description Entries
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N J Lowe
September 1987, Journal of the American Academy of Dermatology,
N J Lowe
February 2017, The Journal of dermatological treatment,
N J Lowe
August 2016, The Journal of dermatological treatment,
N J Lowe
November 1997, The Australasian journal of dermatology,
N J Lowe
January 1996, Annales de dermatologie et de venereologie,
N J Lowe
December 1990, Journal of the American Academy of Dermatology,
N J Lowe
April 1995, Dermatology nursing,
N J Lowe
June 1994, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!